The Emerging and Vector-borne Diseases (EVD) team of ECDC communicates, consults and cooperates with EVD-Net on surveillance, response, prevention, control and preparedness aspects of EVDs and vectors, with particular focus on country needs and country support possibilities.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 May 2023 and includes updates on COVID-19, influenza, Marburg virus disease, poliomyelitis, extensively drug-resistant Pseudomonas aeruginosa, and suspected fungal meningitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-17 May 2023 and includes updates on Legionnaires’ disease, avian or animal influenza (H5), MDR S.Typhi, Marburg virus disease and antifungal-resistant Trichophyton indotineae.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 May 2023 and includes updates on measles, COVID-19, influenza and swine influenza, group A Streptococcal infection, Marburg virus disease, Lassa fever, diphtheria and mpox.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 April - 6 May 2023 and includes updates on COVID-19, influenza, echovirus, Marburg virus, mpox, MERS, and the seizure of a reference laboratory in Sudan.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 April 2023 and includes updates on cholera, avian influenza, COVID-19, invasive meningococcal disease, influenza, Marburg virus disease, and the seizure of a reference laboratory by an armed group.
At the start of European Immunization Week, the ECDC report “Poliomyelitis situation update” reveals that between 2012 and 2021, approximately 2.4 million children in the EU/EEA may have not received three doses of polio-containing vaccines on time. Additionally, the newly published ECDC “Measles Annual Epidemiological Report 2022” highlights the risks when having pockets of an under-vaccinated population or groups not immunised at all.